View E-Mail in Browser

Weekly News

11 June 2024

Hero Image

Register for the ESCMID/ASM conference on drug development with early bird rates!

Join us on the frontline in the fight against Antimicrobial Resistance (AMR). Don’t miss the opportunity to register for our ESCMID/ASM joint conference, where leading minds in the field unite to confront this global crisis. Be sure to secure your space among the limited 350 tickets available.

 

Benefit from our early bird registration fees until 30 June 2024 – with further discounts for ESCMID or ASM members.

 

17

JUN ’24

 
Location   Porto
 
Category   Deadline

ESCMID/ASM conference – Abstract submission


17

JUN ’24

 
Location   Online
 
Category   Extended deadline

How I Manage Common Infectious Diseases in Older Adults


19

JUL ’24

 
Category   Deadline

Study Group Research Grant application

 

Science & Research

Hero Image

Call for ESCMID Ethics Advisory Committee member 2024

We are opening a call for a new member of the ESCMID Ethics Advisory Committee (EEAC), with duration of term until April 2028 (after ESCMID Global). The EEAC is an independent body with the main duty of counselling on specific ethical issues related to ESCMID funded-research projects and scientific behaviour of members in matters related to the society activities. Check out the role description and how to apply on our website.

 
Registration
ESCMID | UN

ESCMID AMR petition for UNGA 2024

In the run-up to the UNGA (UN General Assembly) meeting in New York, USA in September, ESCMID has organised a petition that we would like to share with you and urge you to sign. Antimicrobial resistance is on the agenda for the meeting and we want to really show global leaders how important this issue is and the lasting consequences if we don’t act now. Be sure to sign and send to your respective ministers and other influential politicians asking them to mobilize political attention at the highest level possible.

 

Learn more and download the petition on our website.

 

Education

Hero Image

Join this hybrid course from 16 - 18 July 2024 in Oxford, United Kingdom

Discover the future of Public Health: this course is your gateway to mastering the real-time integration of clinical, laboratory, and genomic information. This immersive experience combines theory with hands-on practice, equipping you with the skills needed for early outbreak detection, syndromic surveillance, and predictive modelling.

 

Registration is open until 15 June 2024.

 
Hero Image

Join this course in Bertinoro, Italy, from 22 - 26 September 2024 to stay updated in maternal and neonatal infections management

Embark on a dynamic journey through the latest interdisciplinary insights with our specialised course. Dive into the epidemiology and burden of infectious diseases in pregnancy and newborns, exploring the pathogenesis of foetal and neonatal damages. Learn the art of pre- and postnatal counselling, essential for comprehensive maternal and child healthcare. Engage in collaborative diagnostic and clinical pathway development for the effective management of infections in pregnant women and newborns. Delve into the realms of prevention and therapy for vertically transmitted infections, staying at the forefront of innovative strategies.

 

This onsite course promises a vibrant blend of enlightening lectures, clinical case presentations by expert scientists in the field, and interactive group discussions.

 

Congress & Events

Hero Image

Check out the ESGS symposium at the ISSSI 2024

The ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) focuses on the challenges posed by Staphylococcus aureus, one of the most frequent bacterial pathogens in both community and healthcare settings. With staphylococcal infections on the rise, we are committed more than ever to understanding S. aureus’ complex pathogenesis and interactions with human hosts. Featured speakers will be Annelies Zinkernagel, Stefano Giulieri and Robert Skov.

 

CMI Logo

European multi-center study to establish MIC and zone diameter epidemiological cut-off (ECOFF) values for Bacillus anthracis


EMA Logo

EMA has recommended granting a marketing authorisation in the European Union (EU) for Ixchiq, the first vaccine in the EU to protect adults 18 years and older against Chikungunya. It is given as a single dose